Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5221371

N#Cc1ccc(N2CC[C@H](N)C2)nc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 4/20 0.68
DPP8 Q6V1X1 3/20 0.68
DPP9 Q86TI2 3/20 0.68
DPP7 Q9UHL4 2/20 0.68
HRH4 Q9H3N8 1/20 0.49
HRH3 Q9Y5N1 1/20 0.49
JAK2 O60674 4/20 0.48
JAK3 P52333 4/20 0.48
JAK1 P23458 3/20 0.48
IRAK4 Q9NWZ3 2/20 0.48
CHEK1 O14757 1/20 0.48
NTRK1 P04629 1/20 0.48
PRKCA P17252 1/20 0.48
CCNA2 P20248 1/20 0.48
CDK2 P24941 1/20 0.48
GSK3B P49841 1/20 0.48
MAPK10 P53779 1/20 0.48
CCNA1 P78396 1/20 0.48
MAP3K9 P80192 1/20 0.48
PRKCQ Q04759 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL950877 0.88 DPP4 (0.51) DPP4DPP8DPP9DPP7JAK2
Trifluoroacetic Acid SCHEMBL2694917 0.84 DPP4 (0.59) DPP4DPP8DPP9DPP7JAK2
Trifluoroacetic Acid SCHEMBL2694915 0.84 DPP4 (0.59) DPP4DPP8DPP9DPP7JAK2
Trifluoroacetic Acid SCHEMBL1023392 0.81 DPP4 (0.56) DPP4DPP8DPP9DPP7CHRM2
SCHEMBL2224211 0.80 MAP4K4 (0.50) DPP4DPP8DPP9DPP7PRKCQ
SCHEMBL1347347 0.80 GPR119 (0.55) DPP4DPP8DPP9DPP7HRH3
Hydrochloric Acid SCHEMBL17687617 0.79 GPR119 (0.54) DPP4DPP8DPP9DPP7JAK2
SCHEMBL2226561 0.78 NOTUM (0.56) DPP4DPP8DPP9DPP7JAK2
Trifluoroacetic Acid SCHEMBL7257025 0.78 DPP4 (0.52) DPP4DPP8DPP9DPP7HRH4
SCHEMBL16718810 0.77 KDM4E (0.50) DPP4DPP8DPP9DPP7JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1399433-B1 FLUOROPYRROLIDINES AS DIPEPTIDYL PEPTIDASE INHIBITORS SMITHKLINE BEECHAM CORP (US) 2007-08-22 EP disclosed
US-7183290-B2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors SMITHKLINE BEECHAM CORPORATION (US) 2007-02-27 US disclosed
US-20040242636-A1 Enzyme inhibitors as antiinflammatory ageents for psoriasis, obesity SMITHKLINE BEECHAM CORPORATION 2004-12-02 US disclosed
EP-1399433-A2 FLUOROPYRROLIDINES AS DIPEPTIDYL PEPTIDASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2004-03-24 EP disclosed
WO-2003002553-A2 FLUOROPYRROLIDINES AS DIPEPTIDYL PEPTIDASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2003-01-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040242636-A1 Enzyme inhibitors as antiinflammatory ageents for psoriasis, obesity DPP4, DPP7, DPP3 DPP4 1/4885DPP8 4/4885DPP9 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.